373 related articles for article (PubMed ID: 28348483)
21. Expression of the EP300, TP53 and BAX genes in colorectal cancer: Correlations with clinicopathological parameters and survival.
Kowalczyk AE; Krazinski BE; Godlewski J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Kiezun J; Sulik M; Kmiec Z
Oncol Rep; 2017 Jul; 38(1):201-210. PubMed ID: 28586030
[TBL] [Abstract][Full Text] [Related]
22. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
[TBL] [Abstract][Full Text] [Related]
23. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].
Lin MX; Wen ZF; Feng ZY; He D
Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
25. Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients.
Peng L; Wang R; Shang J; Xiong Y; Fu Z
Oncotarget; 2017 Feb; 8(9):15057-15070. PubMed ID: 28125800
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-38 in colorectal cancer: a potential role in precision medicine.
Chen F; Zhang F; Tan Z; Hambly BD; Bao S; Tao K
Cancer Immunol Immunother; 2020 Jan; 69(1):69-79. PubMed ID: 31786620
[TBL] [Abstract][Full Text] [Related]
27. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases.
Zeng ZS; Cohen AM; Zhang ZF; Stetler-Stevenson W; Guillem JG
Clin Cancer Res; 1995 Aug; 1(8):899-906. PubMed ID: 9816060
[TBL] [Abstract][Full Text] [Related]
28. Reduced expression of EphA5 is associated with lymph node metastasis, advanced TNM stage, and poor prognosis in colorectal carcinoma.
Gu S; Feng J; Jin Q; Wang W; Zhang S
Histol Histopathol; 2017 May; 32(5):491-497. PubMed ID: 27651378
[TBL] [Abstract][Full Text] [Related]
29. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
30. The clinical significance of forkhead box protein A1 and its role in colorectal cancer.
Ma W; Jiang J; Li M; Wang H; Zhang H; He X; Huang L; Zhou Q
Mol Med Rep; 2016 Sep; 14(3):2625-31. PubMed ID: 27484093
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Correlation Between MFG-E8 Expression Level and Colorectal Cancer.
Jia M; Yao H; Chen C; Wang Y; Wang H; Cui T; Zhu J
Arch Med Res; 2017 Apr; 48(3):270-275. PubMed ID: 28923329
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological significance and prognostic value of Wilms' tumor gene expression in colorectal cancer.
Miyata Y; Kumagai K; Nagaoka T; Kitaura K; Kaneda G; Kanazawa H; Suzuki S; Hamada Y; Suzuki R
Cancer Biomark; 2015; 15(6):789-97. PubMed ID: 26406403
[TBL] [Abstract][Full Text] [Related]
33. IMP3 expression in biopsy specimens of colorectal cancer predicts lymph node metastasis and TNM stage.
Wei Q; Huang X; Fu B; Liu J; Zhong L; Yang Q; Zhao T
Int J Clin Exp Pathol; 2015; 8(9):11024-32. PubMed ID: 26617820
[TBL] [Abstract][Full Text] [Related]
34. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
[TBL] [Abstract][Full Text] [Related]
36. Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer.
Okamura T; Shimada Y; Nogami H; Kameyama H; Kobayashi T; Kosugi S; Wakai T; Ajioka Y
Dis Colon Rectum; 2016 May; 59(5):396-402. PubMed ID: 27050601
[TBL] [Abstract][Full Text] [Related]
37. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
38. CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression.
Zhao LH; Lin QL; Wei J; Huai YL; Wang KJ; Yan HY
Int J Clin Exp Pathol; 2015; 8(1):692-701. PubMed ID: 25755763
[TBL] [Abstract][Full Text] [Related]
39. High expression of ROR2 in cancer cell correlates with unfavorable prognosis in colorectal cancer.
Mei H; Lian S; Zhang S; Wang W; Mao Q; Wang H
Biochem Biophys Res Commun; 2014 Oct; 453(4):703-9. PubMed ID: 25301559
[TBL] [Abstract][Full Text] [Related]
40. Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer.
Ozawa T; Kazama S; Akiyoshi T; Murono K; Yoneyama S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kanazawa T; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Morikawa T; Fukayama M; Watanabe T
Ann Surg Oncol; 2014 Aug; 21(8):2650-8. PubMed ID: 24728738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
